Ataxia Market Set To Witness Significant Growth By 2024-2031: Pfizer, Inc., CRISPR Therapeutics, Sanofi, Bio-Techne Ataxia market is estimated to be valued at US$ 30,880.5 million in 2024 and is ...
Her symptoms were relieved and she did not suffer any motor fluctuation. The drug was adjusted to sinemet (levodopa/carbidopa) 200/50 mg three times daily and pramipexole 0.25 mg three times daily 9 ...